coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Greater Preston PCN, Preston · Health Inequalities Profile

    PCN U09100 · NHS Lancashire and South Cumbria Integrated Care Board · 10 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    95,758

    Registered population

    66.0% aged 18–64

    14.2%

    Aged 65+

    ICB 20.0% · England 17.9%

    13.5%

    Ethnic minority (non-White)

    9.9% Asian · England 9.6%

    47.2%

    In IMD quintile 1

    ICB 30.6% · England 21.0%

    ~37,813

    Core20 residents (est.)

    Resident basis; registered basis ~51,845 · see page 3

    12,257

    Hypertension register

    +6.88% in 3 yrs · England +5.60%

    1,211

    SMI register

    54% of Preston's

    1,719

    COPD register

    Reviews -0.97% in 3 yrs

    Forecast to 2030

    14,587

    Hypertension patients, 2030

    +2,330 on today

    71.4%

    QRISK ≥20% on statins, 2030

    +2.13pp over 3 yrs

    3.7%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    9.3 pp
    MMR dose gap at age five.

    Age-five coverage drops from 95.5% for dose 1 to 86.2% for dose 2 (below the 95.0% target), which may reflect recall gaps, unverified locally.

    -6.1%
    Asthma reviews fell against England growth.

    Annual asthma reviews fell 6.1% over 2023 to 2025 to 63.1% (England +4.4%), leaving a scale gap of 2,052 patients that may reflect recall.

    +15.3%
    Heart failure and BP delivery outpaces England.

    Heart failure reviews rose +15.3% over 2023 to 2025 to 81.0% (England +8.7%), alongside under-80 blood pressure control rising +8.6% (England +3.2%).

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Working-age adults form 66.0% of patients while older people trail England at 14.2%

    The PCN registers 95,758 patients (summing practice lists yields 102,231, requiring period reconciliation). Working-age adults aged 18-64 comprise 66.0% of patients, above Preston (64.9%), the ICB (60.4%) and England (62.7%). Those aged 65+ account for 14.2% (Preston 12.7%, ICB 20.0%, England 17.9%), while aged 0-17 represent 19.8% (Preston 22.4%, ICB 19.6%, England 19.6%). Census resident data indicates an 86.5% White and 9.9% Asian population (Preston 20.2%, ICB 9.4%, England 9.6%), alongside a 13.5% non-White share. Projected list growth to 2030 is 3.0% (Preston 4.3%, ICB 1.7%, England 2.3%) under an unverified projection method.

    Age profile

    0–1719.8%
    18–6466.0%
    65+14.2%

    65+: ICB 20.0%, England 17.9%

    Ethnicity

    White86.5%
    Asian9.9%
    Mixed1.6%
    Black1.1%
    Other0.9%

    Older people · falls rows are Preston local-authority (LA) data, not PCN

    MeasureLocalNorth WestEnglandPeriod
    Falls admissions, 65+, per 100,000 (Preston LA)1,8472,0711,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)85.3%82.9%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)56.5%56.6%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Preston LA)9501,0219552024/25
    Falls deaths, all ages, per 100,000 (Preston LA)13.518.214.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Deprivation and Core20

    Core20 cohort (IMD quintile 1) is 47.2% at PCN level, above Preston (46.4%), NHS Lancashire and South Cumbria Integrated Care Board (30.6%), and England (21.0%), sitting 26.1 percentage points above England. Core20 reflects the most deprived 20% of national areas rather than a local performance target.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Gutteridge96.1% · 4,193 patients
    Dr Ali Guttridge95.9% · 4,265 patients
    New Hall Lane89.7% · 6,536 patients
    Park View82.0% · 5,309 patients
    Park Medical55.0% · 13,316 patients
    Lane Ends43.0% · 4,954 patients
    St. Mary's36.6% · 6,852 patients
    North Preston28.5% · 3,368 patients
    Briarwood27.5% · 2,170 patients
    Kingsfold16.0% · 882 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    1,211

    SMI register

    1.30% recorded prevalence

    565

    Learning disability register

    0.60% recorded prevalence

    44

    Care homes, 1,427 beds

    In the PCN catchment

    9.3%

    Provide unpaid care

    Preston, Census 2021

    The PCN records 1,211 severe mental illness patients (1.3% prevalence; Preston 1.4%, ICB 1.2%, England 1.0%) and 565 learning disability patients (0.6% prevalence; Preston 0.7%, ICB 0.6%, England 0.6%). The catchment includes 44 care homes with 1,427 beds, though site capacity does not confirm patient registrations.

    Severe mental illness: physical health checks

    Severe mental illness recorded prevalence is 1.3% (1,211 patients). Although 3-year BMI recording rose +10.2 pp (England +5.1 pp), 12-month blood pressure checks at 82.1% and BMI checks at 80.0% trail England (83.4% and 82.1%).

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    12,257

    Hypertension register

    +6.88%

    Register growth, 3 yrs

    Preston +5.93% · England +5.60%

    +5.32pp

    BP control, under 80

    ≤140/90 · +0.75pp aged 80+

    +2,330

    More patients by 2030

    Forecast 14,587 (14.98%)

    Hypertension case-finding and control

    Recorded hypertension prevalence is 13.1% (12,257 patients), below Preston (13.8%), England (15.2%), and NHS Lancashire and South Cumbria Integrated Care Board (17.2%). Three-year register change reached +6.9% over 2023 to 2025 (England +5.6%). For patients under 80 with hypertension, blood pressure control to <= 140/90 mmHg improved +8.6% over 2023 to 2025 (England +3.2%) to 66.9% (England 67.8%). For patients aged 80 and over, blood pressure control to <= 150/90 mmHg reached 79.7% (England 81.2%, ICB 81.8%). Lower recorded control among patients aged 80 and over compared with national benchmarks could reflect medication adherence or clinical thresholds, unverified locally; an audit would test this.

    Lipids and statins

    Patients with QRISK >= 20% treated with lipid-lowering therapy reached 66.9% (England 63.6%), and CKD treatment reached 75.9% (England 70.3%). However, statin therapy in diabetic patients aged 40 and over without CVD fell 1.3% over 2023 to 2025 (England +2.1%) to 74.6% (England 73.2%). Falling diabetic statin therapy over three years may indicate uneven annual.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 2026158,012£1.50£1.64£1.86£237,018
    Cardiovascular (all), 2025224,418£3.13£3.38£3.33£702,428

    In 2026, the PCN prescribed 158,012 lipid-regulating items at £1.50 per item (England £1.86, ICB £1.64), spending £56,884 less than at England's unit cost across 158,012 items. Prescribing per 1,000 adults aged 18 and over was 2,056 items (England 4,100, ICB 2,615). Unit cost does not measure prescribing efficiency or appropriateness.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    −6.14%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    −2.02%

    Asthma prevalence, PCN 3-yr % change

    Annual asthma reviews fell 6.1% over 2023 to 2025 (England +4.4%) to 63.1% (Preston 66.8%, ICB 65.0%, England 65.7%), indicating an unadjusted scale gap of 2,052 patients without a recorded review across the 5,566-patient register. Youth asthma prescribing reached 1,653 items per 1,000 aged 5-19 (England 1,488). COPD recorded prevalence is 1.8% (1,719 patients), where 12-month reviews reached 78.2% (England 76.4%) despite falling 1.0% over three years (England +2.8%). Falling asthma review completion alongside elevated youth prescribing could reflect unmonitored exacerbation risk.

    Cancer register and children's immunisation

    Cancer recorded prevalence is 3.2% (2,981 patients; England 3.8%). In Q1 2025/26 immunisations, 6-in-1 coverage at 12 months was 84.5% (below the 95.0% target by 10.5 pp) and 4-in-1 at age 5 was 81.4% (below the 95.0% target by 13.6 pp). For MMR at age 5, first-dose coverage was 95.5%, while second-dose coverage was 86.2% (below the 95.0% target by 8.8 pp), representing a 9.3 pp dose difference.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months84.5%

    England 91.0%

    6-in-1 complete primary course at 24 months89.2%

    England 92.2%

    MMR dose 1 at 24 months88.2%

    England 88.3%

    MMR dose 2 at age 586.2%

    England 82.8%

    4-in-1 pre-school booster at age 581.4%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    52.4%

    Lancashire and South Cumbria ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~2,010

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Lancashire and South Cumbria ICBEnglandNo usable stageStaged cancers
    Breast86.0%85.4%6%1,561
    Prostate42.4%53.2%11%1,404
    Lung31.1%33.8%15%1,374
    Bowel44.2%47.0%13%1,198
    Skin cancer86.1%87.8%21%519

    Across NHS Lancashire and South Cumbria ICB, 52.4% of staged cancers were diagnosed at stage 1 or 2 in 2022 (4,642 of 8,863 known-stage cases), 22.6 pp below the 75.0% national ambition (England 55.3%). Known-stage share was 74.6% (8,863 of 11,883 cases). Early-stage share fell 1.2 pp from 2013 to 2022, requiring 2,005.2 extra early-stage diagnoses yearly to reach the ambition. Stage data was not captured at PCN level. Cervical screening coverage in women aged 25-49 is 62.5% (England 66.8%), falling 2.7% over 2023 to 2025 (England -1.0%), with 45.9% at Park View Surgery, 54.2% at Gutteridge Medical Centre, and 54.9% at The New Hall Lane Practice.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    At Lancashire Teaching Hospitals NHS Foundation Trust, 75.0415% of patients met the 62-day referral to treatment standard (10.0 pp below the 85.0% target), while the ICB achieved 73.619% (11.4 pp below target). For the 28-day faster diagnosis standard, the trust achieved 82.8957% (7.9 pp above the 75.0% standard) and the ICB reached 78.3901% (3.4 pp above standard). On the 31-day combined treatment standard, the trust attained 89.4327% (6.6 pp below the 96.0% standard), compared to 93.6241% across the ICB (2.4 pp below standard). These provider metrics describe acute system performance rather than PCN delivery.

    Pathways within standard (%)LancashireEast LancashireBlackpoolLancashire and South Cumbria ICBEngland
    28-day faster diagnosis (75%)82.9081.5071.3878.3979.32
    31-day treatment (96%)89.4398.1197.9693.6292.50
    62-day referral to treatment (85%)75.0473.1667.4873.6271.16
    Diagnostic waits over 6 weeks (%)LancashireEast LancashireBlackpoolEngland
    MRI2.410.4321.8021.40
    CT14.970.1516.499.92
    Echocardiography13.850.007.5728.48
    Colonoscopy0.000.9513.0830.83
    Gastroscopy0.001.1612.4729.02
    All 15 DM01 tests26.653.2526.5423.14
    Community services activityLancashire residentsLancashire and South Cumbria ICB
    Care contacts126,445193,720
    Referrals20,41529,855
    Patients with a contact47,32065,335

    Community services (residents of Lancashire), Jun 2026 (provisional). In the provisional June 2026 Community Services Dataset, adults aged 65 and over accounted for 56.9% of community contacts among Preston borough residents (72,000 of 126,445 contacts). These borough-level resident figures describe wider community activity rather than PCN-specific service delivery.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Phone access spans 61.1 pp across practices, alongside wide variation in clinical achievement

    In 2025/26, QOF overall achievement ranged from 85.3% at Dr Ali Guttridge Medical Centre to 99.1% at Kingsfold Medical Centre. Vaccination and immunisation domain achievement spanned 76.7 pp, from 15.6% at Park View Surgery to 92.3% at Kingsfold Medical Centre. High overall points awards may conceal marked inter-practice differences in frontline preventive delivery.

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Kingsfold9316.087.0%80.3%97.4%
    New Hall Lane8489.784.1%79.7%86.6%
    Lane Ends Surgery10643.056.3%74.9%81.5%
    St. Mary's10736.680.8%77.9%79.6%
    Gutteridge9096.178.0%78.3%77.8%
    Briarwood9127.565.8%83.6%76.3%
    Park View Surgery9982.071.3%73.4%74.5%
    Dr Ali Guttridge10295.963.8%71.0%73.4%
    Park Medical11255.062.7%71.7%72.7%
    North Preston11728.525.9%76.9%70.8%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNPrestonAssetPCNPreston
    Care homes (catchment)44 (1,427 beds)n/aSchools (catchment)123n/a
    Children's centres78Places of worship9795
    Libraries55Primary schools (LA maintained)3836
    Primary academies1315Special schoolsn/a1

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Preschool MMR second-dose recall

    At age 5 (cohort 247), MMR coverage drops 9.3 pp from 95.5% (dose 1) to 86.2% (dose 2, 8.8 pp below the 95.0% target), reaching 21.4 pp at Dr Ali Guttridge Medical Centre. Moderate effort to run.

    Evidence base: coverage against the 95% target is the direct measure of programme delivery and catch-up need; where coverage clusters low, that decides whether catch-up is organised at practice, PCN, school or outreach level.

    Policy anchor: 10 Year Health Plan, shift from sickness to prevention.

    Option 2

    Standardised annual asthma review recall

    Asthma reviews fell 6.1% over 2023 to 2025 (England +4.4%) to 63.1% (Preston 66.8%, England 65.7%), leaving an unadjusted scale gap of 2,052 patients across the 5,566 register. Moderate effort to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 3

    Learning disability register validation

    Learning disability prevalence is 0.6% (565 patients; Preston 0.7%, England 0.6%), growing +1.3% over 2023 to 2025 (England +5.4%), with a benchmark gap range of -2 to +130 patients. Low cost, quick to run.

    Evidence base: the register is the cohort for the annual health check and LeDeR learning; people with a learning disability die on average 20 years earlier and are a Core20PLUS5 PLUS group.

    Policy anchor: annual health checks for 75% of people aged 14+ on the register (Network Contract DES); Oliver McGowan mandatory training.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Age-stratified case-finding review (p2)Aged 65+Neighbourhood health framework · NHS vaccination strategyPCN
    Core20 healthcare outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    SMI physical health recall (p4)SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    Hypertension control audit (p5)Last BP reading of patients (80+ yrs with hypertension) in the last 12 months is <= 150/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Preschool MMR second dose recall (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Targeted cervical screening recall (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Phone access and triage review (p9)GPPS good overall experience of the practice10YHP, hospital to communityPractice
    Option 1 · Preschool MMR second-dose recall (p12)MMR dose 1 coverage at age 5 · MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Option 2 · Standardised annual asthma review recall (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs) · Asthma management items prescribed per 1000 5-19 PopulationCore20PLUS5 respiratoryPCN
    Option 3 · Learning disability register validation (p12)Learning disability register · Learning disability: QOF prevalence · Registered population75% annual health checks (Network Contract DES) · Oliver McGowanPCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026ICB2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15